Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Prel...
Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data
About this item
Full title
Author / Creator
Publisher
Ankara: Galenos Publishing House
Journal title
Language
English
Formats
Publication information
Publisher
Ankara: Galenos Publishing House
Subjects
More information
Scope and Contents
Contents
Objectives:The aim of this study was to present the preliminary findings of real-world data of sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) in treatment-naive chronic hepatitis C (CHC) patients, which was approved for the first time in treatment-naive patients in Turkey.Materials and Methods:This retrospective, cross-sectional, multicenter and...
Alternative Titles
Full title
Sofosbuvir/Velpatasvir/Voxilaprevir Experience in Treatment-Naive Chronic Hepatitis C Patients: Preliminary Findings of Real World Data
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3200793987
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3200793987
Other Identifiers
ISSN
1307-9441
E-ISSN
2147-2939
DOI
10.4274/vhd.galenos.2023.2023-5-2
